Positioners based on near-field acoustic levitation (NFAL) offer high positioning resolution and bandwidth, primarily along the Z axis, because of the large acoustic Z-stiffness and squeeze film damping.However, their XY-positioning resolution and bandwidth are several orders of magnitude lower because of the limited acoustic stiffness and damping in these directions.In this paper, we increase the XY-stiffness and damping by using a steady-current-based planar electromagnetic trap and eddy current damping technique, resp.Specifically, NFAL is used to levitate a magnetic platform, which is then electromagnetically trapped in the XY-plane.Eddy currents generated by a thin copper plate beneath the levitating platform increase in-plane damping by a factor of 52, thereby reducing vibrations inherent in the NFAL technique.Addnl., the planar coil used for electromagnetic trapping provides multi-axis positioning capabilities.We demonstrate 3-axis linear motion with a root mean square (rms) positioning resolution of better than 20 nm along all axes.The in-plane motion range and bandwidth achieved are 1.42 mm and 16 Hz, resp., while a motion range of 40μm with a positioning bandwidth of 171 Hz is achieved along the Z-axis.

01 Sep 2025·JOURNAL OF ENVIRONMENTAL MANAGEMENT

Linking digital transformation to ESG outcomes: A mixed-methods study on SRM capability and coopetition in supply networks

Article

Author: Routray, Susmi ; Bag, Surajit ; Aytac, Beysül

This study uses a resource-based view to explore the relationships between digital technology investment, digital supplier relationship management capability, coopetition within supply networks, and Environmental, Social and Governance (ESG) performance. The study adopted a mixed-methods approach. Study one employed a quantitative approach, testing a hypothesized serial mediation model using survey data and analyzing it with PROCESS. The study two applied a qualitative study approach. The findings indicate that digital technology investment positively influences ESG performance through digital supplier relationship management capability and coopetition within supply networks. This research provides fresh perspectives on the expanding body of work regarding digital transformation and ESG performance by introducing a unique serial mediation model that highlights the significance of two mediators. Additionally, the results assist managers in enhancing their ESG performance in the digital age.

01 Aug 2025·ACTA PSYCHOLOGICA

Green HRM, employee pro-environmental behavior, and environmental commitment

Article

Author: Chaudhary, Aparna ; Kumar, Vinod ; Oberoi, Sarbjit Singh ; Kumar, Rupesh ; Bangwal, Deepak

In the field of green human resource management (GHRM), green practices and employee environmental commitment (EEC), there is a need to investigate these dynamics in diverse organizational contexts, such as the hospitality industry. Within hospitality industry, employee behavior is a major factor in determining environmental commitment. This study investigates the connection between GHRM practices and pro-environmental behavior (task-related and proactive pro-EB) among hospitality employees, aiming to enhance their environmental dedication. To conduct this study, we reached out to the HR managers of four hotels in India and collected 281 filled responses through a convenience sampling technique. Drawing on empirical evidence from India, the study supports the abilities, motivation, and opportunities theory and the social exchange theory framework to understand the GHRM mechanism with employee pro-EB and environmental commitment within the hospitality industry. The developed hypotheses and conceptual model used the structural equation modeling technique to test this mechanism. The study findings demonstrated that GHRM promotes pro-EB among hospitality industry employees to improve environmental commitment. This study adopts a unique approach to GHRM by considering the influence of employees' proactive and task-related pro-EB in enhancing their environmental commitment in the hospitality sector.

News (Medical) associated with Institute of Management Technology

05 Dec 2023

·www.prnewswire.com

Prime Therapeutics announces Ken Bodmer as chief financial officer

EAGAN, Minn., Dec. 5, 2023 /PRNewswire/ -- Today, Prime Therapeutics LLC/Magellan Rx Management LLC (Prime/MRx) announces that it has appointed Ken Bodmer as chief financial officer (CFO), effective Dec. 4, 2023. Continue Reading Ken Bodmer, chief financial officer, Prime Therapeutics "Ken is an extraordinary leader with a deep understanding of the markets we serve and brings a unique blend of financial and operational expertise coupled with a proven track record of success," said Mostafa Kamal, president and chief executive officer at Prime. "I've always believed the role of CFO is about much more than managing the numbers. It's about shaping the financial strategy of the company in ways that align with our core values and mission and Ken is the right person to do just that." Bodmer has more than 20 years of experience in business and financial leadership in both pharmacy benefit management and specialty pharmacy. Prior to joining Prime/MRx, Bodmer most recently served as both president and CFO at PANTHERx Rare, a rare-disease pharmacy focused on caring for patients with complex conditions. Prior to joining PANTHERx, Bodmer held leadership positions at CVS Health. His previous experience also includes both CFO and chief operating officer roles at Accredo, as well as key financial leadership roles at Medco (now Express Scripts) and Catamaran (now OptumRx). "I am honored to join Prime/MRx at such a pivotal time in the health care industry," said Bodmer. "Prime/MRx's capabilities, reach and unique vision position the company to reimaging pharmacy management at a time when it matters more than ever. I'm looking forward to being part of that success." Bodmer completed his Master of Business Administration from Seton Hall University and his Bachelor of Science in Accounting from Villanova University. He is a member of the Financial Executive Institute, the Institute of Management Accountants, the American Institute of CPAs, and the Academy for Healthcare Management. About Prime Therapeutics + Magellan Rx Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization serving health plans, employers and government programs. Prime is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Magellan Rx Management LLC, a Prime Therapeutics LLC Company, is a pioneer in specialty and medical drug management and a leader in serving public sector state government programs. Together Prime and Magellan Rx provide a wide range of clients with solutions that bridge the distance between medical and pharmacy management. For more information visit primetherapeutics.com and magellanrx.com or follow us on X (Twitter) at @Prime_PBM and @Magellan_Rx. SOURCE Prime Therapeutics LLC

Executive Change

100 Deals associated with Institute of Management Technology

100 Translational Medicine associated with Institute of Management Technology

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 18 Sep 2025

No data posted

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis

Institute of Management Technology

Overview

Related

Corporation Tree

Pipeline

Pipeline Snapshot as of 18 Sep 2025

Deal

Translational Medicine

Profit

Grant & Funding(NIH)

Investment

Financing